The Silent Crisis

The Silent Crisis

“Fungal infections are an overlooked emerging disaster” Kainz et al., Microbial Cell, June 2020

The Silent Crisis

The Silent Crisis

“Fungal infections are an overlooked emerging disaster” Kainz et al., Microbial Cell, June 2020

The Silent Crisis

The Silent Crisis

“Fungal infections are an overlooked emerging disaster” Kainz et al., Microbial Cell, June 2020

The Silent Crisis

The Silent Crisis

“Fungal infections are an overlooked emerging disaster” Kainz et al., Microbial Cell, June 2020

The Silent Crisis

The Silent Crisis

“Fungal infections are an overlooked emerging disaster” Kainz et al., Microbial Cell, June 2020

The Silent Crisis

The Silent Crisis

“Fungal infections are an overlooked emerging disaster” Kainz et al., Microbial Cell, June 2020

The Silent Crisis

The Silent Crisis

“Fungal infections are an overlooked emerging disaster” Kainz et al., Microbial Cell, June 2020

The Silent Crisis

The Silent Crisis

“Fungal infections are an overlooked emerging disaster” Kainz et al., Microbial Cell, June 2020

The Silent Crisis

The Silent Crisis

“Fungal infections are an overlooked emerging disaster” Kainz et al., Microbial Cell, June 2020

The Silent Crisis

The Silent Crisis

“Fungal infections are an overlooked emerging disaster” Kainz et al., Microbial Cell, June 2020

The Silent Crisis

The Silent Crisis

“Fungal infections are an overlooked emerging disaster” Kainz et al., Microbial Cell, June 2020

The Silent Crisis

The Silent Crisis

“Fungal infections are an overlooked emerging disaster” Kainz et al., Microbial Cell, June 2020

The Silent Crisis

The Silent Crisis

“Fungal infections are an overlooked emerging disaster” Kainz et al., Microbial Cell, June 2020

 

IPO 2021

 Biosergen intends to list its shares on Nasdaq First North Growth Market Stockholm

 
Biosergen avser att notera sina aktier på Nasdaq First North Growth Market Stockholm

Events, Presentations and Media


Financial Calender

Report/event Expected date
Year-end report for January-December 2021 March 31, 2022
Annual report 2021 March 31, 2022
Annual General Meeting 2022 April 28, 2022
Interim report for April-June 2022 (Q2) August 31, 2022
Interim report for July – September 2022 (Q3) November 30, 2022

 

Company presentation

   Biosergen Introduction   link

   Introduction to Biosergen and CEO Peder M. Andersen Video  link

 

Media

   2021.05.27 Biostock   link

   Biostock interview June 1, 2021 Video   link

 

Press Releases

 

19-05-2021     Biosergen intends to list its shares on Nasdaq First North Growth Market Stockholm       En

                          Biosergen avser att notera sina aktier på Nasdaq First North Growth Market Stockholm       Se


01-06-2021     Biosergen-and-mucormycosis-in-India.pdf       En